Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hydrocortisone valerate is a synthetic corticosteroid used topically to treat inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, such as eczema, dermatitis, allergies, and rashes. It is classified as a medium-potency topical steroid. The drug exerts anti-inflammatory, antipruritic (anti-itch), and vasoconstrictive effects. Its mechanism of action involves the induction of phospholipase A2 inhibitory proteins (lipocortins), which suppress the release of arachidonic acid from membrane phospholipids—thereby reducing the biosynthesis of pro-inflammatory mediators like prostaglandins and leukotrienes[1][3][4][5]. Hydrocortisone valerate is available by prescription in cream or ointment formulations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on hydrocortisone valerate.